Involving patients in research what have we done and how did we do it? Jean R. Slutsky, Patient-Centered Outcomes Research Institute (PCORI) Foredrag, Brukermedvirkning i helseforskning, fra ord til handling. Diakonhjemmet Sykehus 4. november 2014.
Janet Schnall's presentation about Evidence Based Nursing Resources at our free monthly webcast. Recording available at https://webmeeting.nih.gov/p96958659/
Weitzman 2013 Relative patient benefits of a hospital-PCMH collaboration with...CHC Connecticut
Anuj K Dalal presents information on a PCORI research grant: Relative patient benefits of a hospital-PCMH collaboration within an ACO to improve care transitions.
Involving patients in research what have we done and how did we do it? Jean R. Slutsky, Patient-Centered Outcomes Research Institute (PCORI) Foredrag, Brukermedvirkning i helseforskning, fra ord til handling. Diakonhjemmet Sykehus 4. november 2014.
Janet Schnall's presentation about Evidence Based Nursing Resources at our free monthly webcast. Recording available at https://webmeeting.nih.gov/p96958659/
Weitzman 2013 Relative patient benefits of a hospital-PCMH collaboration with...CHC Connecticut
Anuj K Dalal presents information on a PCORI research grant: Relative patient benefits of a hospital-PCMH collaboration within an ACO to improve care transitions.
Our main involvement with your clinical research recruitment program concludes with processing the responses to your mailer. As our staff members direct the respondents to your site, you can begin conducting final interviews to complete the clinical trial recruitment process.
a brief overview about how and why to practice evidence based medicine, its clinical application, what it is and what it is not? benefits and challenges
Patients Recruitment Forecast in Clinical TrialsCognizant
Inaccurate patient recruitment forecasts for clinical trials cost pharmaceuticals and medical device manufacturers a huge amount of resources each year. We offer descriptions and examples of applying stochastic and non-stochastic approaches to increase accuracy in this crucial stage of drug testing.
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
Best strategies for successful recruitment and retentionTrialJoin
Best strategies for successful recruitment and retention for clinical research studies
Contact info@trialjoin.com for more information about patient recruitment help, obtaining new studies or help with site management.
discussing all aspects of evidence based medicine, Introduction
History of EBM
Need of EBM
Steps to practice
Discussion - advantages/disadvantages/critical analysis
Evidence Based Practice is the integration of clinical expertise, patient values, and the best research evidence into the decision making process for patient care.
Clinical expertise refers to the clinician’s cumulated experience, education and clinical skills. The patient brings to the encounter his or her own personal preferences and unique concerns, expectations, and values.
The best research evidence is usually found in clinically relevant research that has been conducted using sound methodology.
Knowledge transfer, and evidence informed health policy-minster's meetingDr Ghaiath Hussein
A presentation given to the highest executive body in the Federal Ministry of Health in Sudan, which led to the adoption of a new evidence-based policy.
Our main involvement with your clinical research recruitment program concludes with processing the responses to your mailer. As our staff members direct the respondents to your site, you can begin conducting final interviews to complete the clinical trial recruitment process.
a brief overview about how and why to practice evidence based medicine, its clinical application, what it is and what it is not? benefits and challenges
Patients Recruitment Forecast in Clinical TrialsCognizant
Inaccurate patient recruitment forecasts for clinical trials cost pharmaceuticals and medical device manufacturers a huge amount of resources each year. We offer descriptions and examples of applying stochastic and non-stochastic approaches to increase accuracy in this crucial stage of drug testing.
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
Best strategies for successful recruitment and retentionTrialJoin
Best strategies for successful recruitment and retention for clinical research studies
Contact info@trialjoin.com for more information about patient recruitment help, obtaining new studies or help with site management.
discussing all aspects of evidence based medicine, Introduction
History of EBM
Need of EBM
Steps to practice
Discussion - advantages/disadvantages/critical analysis
Evidence Based Practice is the integration of clinical expertise, patient values, and the best research evidence into the decision making process for patient care.
Clinical expertise refers to the clinician’s cumulated experience, education and clinical skills. The patient brings to the encounter his or her own personal preferences and unique concerns, expectations, and values.
The best research evidence is usually found in clinically relevant research that has been conducted using sound methodology.
Knowledge transfer, and evidence informed health policy-minster's meetingDr Ghaiath Hussein
A presentation given to the highest executive body in the Federal Ministry of Health in Sudan, which led to the adoption of a new evidence-based policy.
Overview of the Patient-Centered Outcomes Research Institute (PCORI), how PCORI views Patient-Centered Outcomes Research and how this is related to PCORI’s major funding mechanisms.
Cihr guest presentation and webinar afternoon talk - january 2014Simon Denegri
Presentation on public involvement and engagement in health research: why, how and what next? Given to the staff of the Canadian Institutes for Health Research (CIHR), Ottawa, Canada, 2014
This talk was given to the Alberta Cancer Foundation in Calgary, January 2015. It looks at different approaches to public involvement in research funding by UK charities. It also includes some updated slides on the results of the Breaking Boundaries review.
Welcome Remarks and Overview of CTSI ResourcesUCLA CTSI
Welcome Remarks and Overview of CTSI Resources
Steven Dubinett, MD
Director, UCLA Clinical and Translational Science Institute
President/CEO, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center
Slide presentation for the June 4, 2014 joint PCORI/ National Institute on Aging (NIA) of the National Institutes of Health webinar. This webinar announced the selection of the research team that will carry out a major, five-year, $30 million patient-centered study of the effectiveness of individually tailored care plans to help older individuals avoid falls and related injuries.
The slide presentation that preceded of the annual Health Datapalooza in Washington DC, PCORI was pleased to participate in the latest installment in the Health Data Consortium and PricewaterhouseCoopers (PwC) Innovators in Health Data Series, a webinar featuring PCORI Executive Director Joe Selby, MD, MPH; NIH Director and PCORI Board of Governors member Francis Collins, MD, PhD; and Philip Bourne, PhD, NIH’s Associate Director for Data Science.
The slide presentation from PCORI'S Advisory Panel on Assessment of Prevention, Diagnosis, and Treatment Options April 28-29, 2014 meeting in Alexandria, VA.
The slide presentation from the combined meeting of PCORI'S Advisory Panels on Patient Engagement and Addressing Disparities April 28, 2014 meeting in Alexandria, VA.
Slide presentation from Day Two of the PCORnet Partners meeting. The January 21-2, 2014 meeting took place at the Brookings Institute. This event launched the development of the nation’s most ambitious and promising clinical research network aimed at delivering high quality care through patient-centered outcomes research.
Slide presentation from Day One of the PCORnet Partners meeting. The January 21-2, 2014 meeting took place at the Brookings Institute. This event launched the development of the nation’s most ambitious and promising clinical research network aimed at delivering high quality care through patient-centered outcomes research.
Slide presentation from the October 30, 2013 webinar which described the process and rationale for PCORI’s unique approach to reviewing research proposals for funding.
Slide presentation from the November 13, 2013 webinar. This webinar was an opportunity to learn more about the Tier 1 Pipeline Awards, what type of projects PCORI is looking to fund, and how to apply.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
1. The National Press Club – Washington, D.C.
February 27, 2012
Patient-Centered Outcomes
Research Institute
National Patient and
Stakeholder Dialogue
Join the Conversation on Twitter: #PCORIdialogue
2. The National Patient and Stakeholder Dialogue
Washington, D.C.
February 27, 2012
Joe Selby, MD, MPH, Executive Director
Introduction to the National Patient
and Stakeholder Dialogue
Join the Conversation on Twitter: #PCORIdialogue
3. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
The National Patient and Stakeholder Dialogue
Washington, D.C.
February 27, 2012
Sharon Levine, MD, Member, PCORI Board of Governors
Receiving and Incorporating Public
Input
Join the Conversation on Twitter: #PCORIdialogue
4. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Process for Public Input on National
Priorities and Research Agenda
• Formal Public Comment Period (January 23 – March 15)
• Submit formal comments at www.pcori.org/provide-input.
• All comments are displayed on the website in real time.
• Additional forums to obtain input
• Patient, caregiver and clinician focus groups.
• Individual meetings with diverse mix of stakeholders.
• Incorporating input received
• PCORI will review all input received and publish a report with
explanation of how it led to changes in priorities and agenda.
• Revised National Priorities and Research Agenda will be adopted by
Board of Governors during a special public meeting in April.
4
5. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
The National Patient and Stakeholder Dialogue
Washington, D.C.
February 27, 2012
Harlan M. Krumholz, MD, SM, Member, PCORI Board of Governors
National Priorities and Research
Agenda
Join the Conversation on Twitter: #PCORIdialogue
12. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Science 9 October 1998:
Vol. 282 no. 5387 pp. 245-246
Outcomes Research: Measuring
the End Results of Health Care
Carolyn M. Clancy and John M. Eisenberg
12
13. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
“Outcomes research—the study
of the end results of health
services that takes patients'
experiences, preferences, and
values into account—.”
13
14. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
“Outcomes research—the study
of the end results of health
services that takes patients'
experiences, preferences, and
values into account—is intended
to provide scientific evidence
relating to decisions made by all
who participate in health care.”
14
20. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
• “Given my personal characteristics and
conditions, what may happen to me?”
• “What are my options and the benefits
and harms of those options?”
• “What can I do…?”
• “What can the health system do…?”
20
29. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
National Priorities and Research Agenda
Must be approved before major funding can begin
National
Priorities
Research
Agenda
Funding
Announcements
29
30. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Source: Affordable Care Act. Subtitle D—Patient-Centered Outcomes Research. PUBLIC LAW 111–148—MAR. 23, 2010.
National Priorities for Research
“The Institute shall identify national priorities for research, taking
into account factors of disease incidence, prevalence, and burden
in the United States (with emphasis on chronic conditions), gaps in
evidence in terms of clinical outcomes, practice variations and
health disparities in terms of delivery and outcomes of care, the
potential for new evidence to improve patient health, well-being,
and the quality of care, the effect on national expenditures
associated with a health care treatment, strategy, or health
conditions, as well as patient needs, outcomes, and preferences,
the relevance to patients and clinicians in making informed health
decisions, and priorities....”
30
31. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Research Agenda
Source: Affordable Care Act. Subtitle D—Patient-Centered Outcomes Research. PUBLIC LAW 111–148—MAR. 23, 2010.
“The Institute shall establish and update a research project
agenda for research to address the priorities identified
under subparagraph (A), taking into consideration the types
of research that might address each priority and the
relative value (determined based on the cost of
conducting research compared to the potential usefulness
of the information produced by research) associated with
the different types of research, and such other factors as
the Institute determines appropriate.”
31
37. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Improving
Communication and
Dissemination
Accelerating PCOR
and Methodological
Research
Addressing
Disparities
Improving Health
Care Systems
Improving Patient and
Caregiver Decisions
Emphasis on
comparing strategies
Priorities
37
38. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Proposed PCORI Criteria
Impact on Health of Individuals and Populations
Probability of Improvability via Research
Address Current Gaps in Knowledge
Address Variation in Care
Improved Health Care System Performance
Current Health Disparities
Potential to Influence Decision Making
Novel Use of Technology
Efficient Use of Research Resources
From Board
In Statute
Developing PCORI’s Research Agenda
Priority
Themes
Proposed
PCORI
Criteria
PCORI
Research
Agenda
38
39. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
...compare strategies
where better evidence is
needed to support
decision-making by
patients, caregivers, and
health care professionals.
Research Agenda Item From a National Priority
Improving
Patient and
Caregiver
Decisions
PCORI Criteria
39
41. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
PCORI’s Path from Priorities to Research
Patients can Use
41
Future priorities and agendas will be informed by the development process,
ongoing stakeholder engagement, and PCORI’s research results.
42. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
-----Original Message-----
From: xxxx
To: Krumholz, Harlan
Subject: PCORI Pilot Grants
“…it fundamentally changed the way we think
about patient engagement in research, from
being passively observed subjects to
thinking creatively how to engage them in
the design of our research - the way we
design the study, how we craft our
interventions and what outcomes we measure.”
42
46. PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
The National Press Club – Washington, D.C.
February 27, 2012
Patient-Centered Outcomes
Research Institute
National Patient and
Stakeholder Dialogue
Join the Conversation on Twitter: #PCORIdialogue
47. The National Patient and Stakeholder Dialogue
Washington, D.C.
February 27, 2012
Gail Hunt, Member, PCORI Board of Governors
Introduction to the Public Comment
Period
Join the Conversation on Twitter: #PCORIdialogue
48. The National Press Club – Washington, D.C.
February 27, 2012
Patient-Centered Outcomes
Research Institute
National Patient and
Stakeholder Dialogue
Join the Conversation on Twitter: #PCORIdialogue
49. The National Patient and Stakeholder Dialogue
Washington, D.C.
February 27, 2012
Larry Becker, Member, PCORI Board of Governors
Harlan Weisman, MD, Member, PCORI Board of Governors
Ellen Sigal, PhD, Member, PCORI Board of Governors
Observations from PCORI Board
Members
Join the Conversation on Twitter: #PCORIdialogue
50. The National Press Club – Washington, D.C.
February 27, 2012
Patient-Centered Outcomes
Research Institute
National Patient and
Stakeholder Dialogue
Join the Conversation on Twitter: #PCORIdialogue